$CGTX
Cognition Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CGTX up today? It is at $1.01 (+5.57%), and our scanner flagged it 3 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CGTX spikes, and full due diligence on CGTX — key stats, earnings, dilution and insider activity. Free.
Get free $CGTX alerts the moment volume spikes
Our scanner flagged $CGTX 3 times in the last 30 days. Create a free account to track $CGTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $1.01
- Change today
- +5.57%
- Previous close
- $0.957
- 52-week range
- $0.550 – $3.83
- Market cap
- $95M
- Institutional own.
- 26.86%
- Total held
- 37.7%
- Tradeable float
- 59.2M 62% of shares · after 11% insiders + 27% institutions
- Short interest
- 8.9M ▼ -8% vs prior · as of 2026-07-31
- Short % of float
- 15.1%
- Days to cover
- 21.1d
- Avg daily volume
- 1.6M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5mthin
- 0.0x
- 15mthin
- 0.0x
- 1hthin
- 0.0x
- 1D
- --
Get free CGTX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $CGTX up today?
Here is the latest on CGTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CGTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystCOGNITION THERAPEUTICS INC: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying3 open-market buys5 buys, 0 sells last 3 months (14/12 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Fletcher Aaron G.L. Director | Acquired (grant/award) | +25K 0.03% of company | added 44% | 81K | n/a | Jun 17, 26 |
Richstone Ellen B Director | Acquired (grant/award) | +25K 0.03% of company | added 43% | 84K | n/a | Jun 17, 26 |
Wallace Peggy Director | Acquired (grant/award) | +25K 0.03% of company | added 29% | 111K | n/a | Jun 17, 26 |
Monia Brett P Director | Acquired (grant/award) | +25K 0.03% of company | added 52% | 74K | n/a | Jun 17, 26 |
Khattar Jack A. Director | Acquired (grant/award) | +25K 0.03% of company | added 52% | 74K | n/a | Jun 17, 26 |
Doyle John Brendan Officer | Sold (automatic/other) | -9K | sold 1.4% | 619K | $11K at $1.28 | May 1, 26 |
Caggiano Anthony Officer | Bought (open market) | +10K 0.01% of company | added 1.2% | 875K | $11K at $1.11 | Apr 16, 26 |
Ricciardi Lisa Officer | Bought (open market) | +9K | added 0.5% | 1.72M | $10K at $1.10 | Apr 16, 26 |
Doyle John Brendan Officer | Bought (open market) | +10K 0.01% of company | added 1.6% | 628K | $11K at $1.13 | Apr 16, 26 |
Caggiano Anthony Officer | Sold (automatic/other) | -5K | sold 0.5% | 865K | $5K at $1.12 | Feb 15, 26 |
Doyle John Brendan Officer | Sold (automatic/other) | -2K | sold 0.3% | 618K | $2K at $1.12 | Feb 15, 26 |
Ricciardi Lisa Officer | Sold (automatic/other) | -6K | sold 0.3% | 1.71M | $7K at $1.12 | Feb 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
UnavailableWe could not reach SEC EDGAR, so the dilution check did not run for $CGTX. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.
$CGTX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$CGTX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to CGTX
Comparable names in biological products, (no diagnostic substances), closest in size first.
CGTX stock FAQ
Why is $CGTX up today?
Here is the latest on CGTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CGTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the CGTX stock price today?
CGTX last traded at $1.01, up 5.57% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live CGTX alerts?
The CGTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CGTX 3 times in the last 30 days.
What exchange is CGTX on?
CGTX (Cognition Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $95M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is CGTX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CGTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.